[1]
2020. Health-Related Quality of Life (HRQL) in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC) Treated with Cemiplimab: Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s122. DOI:https://doi.org/10.25251/skin.4.supp.122.